Projektbeschreibung
Dem metabolischen Syndrom ein Schnippchen schlagen
Das metabolische Syndrom betrifft mehr als ein Viertel der Weltbevölkerung und kann zu mehreren schweren Gesundheitsstörungen wie Schlaganfall, Krebs, Diabetes, Alzheimer und Herzerkrankungen führen. Viszerale Adipositas ist ein wesentliches Anzeichen und trägt zur Insulinresistenz bei, die eine der Hauptursachen für das metabolische Syndrom darstellt. Das EU-finanzierte Projekt INNOPREFAT zielt darauf ab, eine natürliche Lösung zur Bekämpfung des metabolischen Syndroms zu entwickeln, indem eine Lebensmittelformulierung namens MetabolAid® geschaffen wird. Das Produkt wird unter Verwendung von Kräuterextrakten von einem angesehenen spanischen Unternehmen namens Monteloeder hergestellt. MetabolAid® wurde zur Vorbeugung und Behandlung von Adipositas und metabolischem Syndrom konzipiert und zeichnet sich durch eine einzigartige synergetische Formel, wissenschaftliche Beweise, Wirksamkeit und eine transparente Lieferkette aus.
Ziel
Monteloeder is a global developer, manufacturer and distributor of ingredients and formulations for the nutrition and cosmetics industry. It is committed to identifying and developing safe and effective ingredients derived from natural plants that deliver measureable benefits to consumers. Founded in 1996, Monteloeder today has sales in more than 38 countries and operates offices in Europe, US and Asia.
INNOPREFAT is the result of a long process led by Monteloeder to discover a natural solution to address one of the major epidemics of our time: Metabolic Syndrome (MetS). MetS can lead to serious diseases and conditions, including diabetes type-2, stroke, Alzheimer’s, cancer and heart disease. It affects more than 25% of the world’s population and represents a major and escalating global public health problem and clinical challenge. In Europe, about 8-18% of total adult healthcare expenditure is metabolic syndrome related.
The Business Model and the solution (MetabolAid®) are built around three dimensions: 1. A superior quality product based on a synergistic blend of two herbal extracts, which is supported by an extensive and rigorous scientific programme that demonstrates its effectiveness in improving MetS, as well as its safety and its economic viability. 2. A fully traceable, transparent and efficient supply chain, which guarantees that the product is natural, sustainably produced, completely safe and that it can be included in the main food matrices. 3. Global marketing approach includes a novel and original strategy: we will support our B2B clients with mobile phone health technology to manage end-consumer’s experience with the product and improve their levels of compliance, which in turn will enhance efficacy.
Monteloeder believes that those are the dimensions that will determine how ingredients must be designed, developed, produced and marketed to address the big changes in consumer preferences that are already taking place in the market.
Wissenschaftliches Gebiet
- natural sciencescomputer and information sciencescomputer securitydata protection
- medical and health sciencesbasic medicinepharmacology and pharmacypharmacokinetics
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- medical and health sciencesclinical medicinehepatology
- medical and health scienceshealth sciencesnutritionobesity
Schlüsselbegriffe
Programm/Programme
- H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme
- H2020-EU.3.2.4. - Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy
- H2020-EU.3.2.1. - Sustainable agriculture and forestry
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.2.2. - Sustainable and competitive agri-food sector for a safe and healthy diet
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-SMEINST-2-2016-2017
Finanzierungsplan
SME-2 - SME instrument phase 2Koordinator
03203 Elche
Spanien
Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).